Another study shows PPHN risk with SSRI exposure
A new study, published in the January 12 issue of the British Medical Journal, adds more evidence that antidepressants known as selective serotonin reuptake inhibitors, or SSRIs, when used during pregnancy, can increase the chances that the newborn will have a life-threatening lung defect known as persistent pulmonary hypertension (PPHN).







